Price T Rowe Associates Inc Covetrus, Inc. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$20.69 - $20.91 $37.7 Million - $38.1 Million	-1,822,959 Reduced 96.04%	75,142 $1.57 Million
Q2 2022 Aug 15, 2022	BUY	$13.8 - $20.82 $917,410 - $1.38 Million	66,479 Added 3.63%	1,898,101 $39.4 Million
Q1 2022 May 16, 2022	SELL	$15.96 - $18.87 $17.7 Million - $21 Million	-1,110,574 Reduced 37.75%	1,831,622 $30.8 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $20.37 $38.8 Million - $47.1 Million	-2,313,781 Reduced 44.02%	2,942,196 $58.8 Million
Q3 2021 Nov 15, 2021	SELL	$18.14 - $27.03 $20.5 Million - $30.6 Million	-1,131,339 Reduced 17.71%	5,255,977 $95.3 Million
Q2 2021 Aug 16, 2021	SELL	$25.24 - $30.86 $30.7 Million - $37.6 Million	-1,216,969 Reduced 16.0%	6,387,316 $172 Million
Q1 2021 May 17, 2021	SELL	$28.29 - $39.89 $37 Million - $52.1 Million	-1,306,810 Reduced 14.66%	7,604,285 $228 Million
Q4 2020 Feb 16, 2021	BUY	$24.45 - $31.59 $218 Million - $282 Million	8,911,095 New	8,911,095 $256 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.